<VariationArchive RecordType="classified" VariationID="928699" VariationName="NM_000397.4(CYBB):c.1415del (p.Gly472fs)" VariationType="Deletion" Accession="VCV000928699" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2020-06-22" MostRecentSubmission="2020-06-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="917368" VariationID="928699">
      <GeneList>
        <Gene Symbol="CYBB" FullName="cytochrome b-245 beta chain" GeneID="1536" HGNC_ID="HGNC:2578" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.1-11.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37780059" stop="37813461" display_start="37780059" display_stop="37813461" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37639269" stop="37672713" display_start="37639269" display_stop="37672713" Strand="+" />
          </Location>
          <OMIM>300481</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000397.4(CYBB):c.1415del (p.Gly472fs)</Name>
      <CanonicalSPDI>NC_000023.11:37806485:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37806486" stop="37806486" display_start="37806486" display_stop="37806486" variantLength="1" positionVCF="37806485" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37665739" stop="37665739" display_start="37665739" display_stop="37665739" variantLength="1" positionVCF="37665738" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G472fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_53" sequenceAccession="LRG_53">
            <Expression>LRG_53:g.31471del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_53t1" sequenceAccession="LRG_53t1">
            <Expression>LRG_53t1:c.1415del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.37665740del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.37665740del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.37806487del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.37806487del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009065.1" sequenceAccession="NG_009065" sequenceVersion="1" change="g.31471del">
            <Expression>NG_009065.1:g.31471del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000397.4" sequenceAccession="NM_000397" sequenceVersion="4" change="c.1415del" MANESelect="true">
            <Expression>NM_000397.4:c.1415del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000388.2" sequenceAccession="NP_000388" sequenceVersion="2" change="p.Gly472fs">
            <Expression>NP_000388.2:p.Gly472fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1929563459" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000397.4(CYBB):c.1415del (p.Gly472fs) AND Granulomatous disease, chronic, X-linked" Accession="RCV001192989" Version="1">
        <ClassifiedConditionList TraitSetID="3042">
          <ClassifiedCondition DB="MedGen" ID="C1844376">Granulomatous disease, chronic, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-06-22" MostRecentSubmission="2020-06-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11162142</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20729109</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30237823</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30470980</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30506560</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9585602</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3042" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1398" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CYTOCHROME b-NEGATIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Granulomatous disease, chronic, X-linked</ElementValue>
                <XRef ID="MONDO:0010600" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, SOMATIC MOSAIC</ElementValue>
                <XRef Type="Allelic variant" ID="300481.0021" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CGDX</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CGD</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">X-CGD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis). Granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. While CGD may present anytime from infancy to late adulthood, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</Attribute>
                <XRef ID="NBK99496" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876374</ID>
                <ID Source="BookShelf">NBK99496</ID>
              </Citation>
              <XRef ID="379" DB="Orphanet" />
              <XRef ID="C1844376" DB="MedGen" />
              <XRef ID="MONDO:0010600" DB="MONDO" />
              <XRef Type="MIM" ID="306400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2669814" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000397.3:c.1415del|MedGen:C1844376" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001361487" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11162142</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9585602</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20729109</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30237823</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30470980</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30506560</ID>
          </Citation>
          <Comment>Variant summary: CYBB c.1415delG (p.Gly472AlafsX30) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 182515 control chromosomes (gnomAD). The variant, c.1415delG, has been reported in the literature in multiple individuals affected with X-linked Chronic Granulomatous Disease (Rae_1998, Roos_2010, Fernando_2018, Kulkarni_2018, Kutukculer_2018), and in several cases the diagnosis was reported to be confirmed by functional studies, demonstrating a biochemical defect in patient samples (e.g. Rae_1998, Kutukculer_2018, Fernando_2018). These data indicate that the variant is likely to be associated with disease. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000397.3:c.1415del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Chronic granulomatous disease, X-linked</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1844376" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2669814" TraitType="Disease" MappingType="Name" MappingValue="Chronic granulomatous disease, X-linked" MappingRef="Preferred">
        <MedGen CUI="C1844376" Name="Granulomatous disease, chronic, X-linked" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

